CWA
IRWD icon

Carolina Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Carolina Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,492
Closed -$5.24K – 289
2026
Q1 		$5.24K Buy
+1,492
New +$6.12K ﹤0.01% 223

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Carolina Wealth Advisors's IRWD Position: Q2 2026 in Review

Carolina Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 1,492 shares — an estimated $5.24K sold.

Carolina Wealth Advisors first reported a position in IRWD in Q1 2026 and held it in 1 quarter. The position peaked at $5.24K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Carolina Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Carolina Wealth Advisors sold 1,492 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $5.24K.
  • Carolina Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Carolina Wealth Advisors's Ironwood Pharmaceuticals position peaked at $5.24K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.